Up to 100,000 lives could be saved every year if a known drug were given to seriously bleeding trauma patients, says a report from a global trial.
The research reported in The Lancet shows that tranexamic acid (TXA), which helps blood to clot, could lower the risk of dying by 15%.
Developing countries would benefit most from this treatment, say researchers after studying 20,000 patients.
No comments:
Post a Comment